Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ziprasidone: a novel psychotropic with unique properties.

Christos Ballas1, Calvin Yang, John O'Reardon

  • 1PEEC, Ground Floor, Ravdin Building, 3400 Spruce St., Philadelphia, PA 19104, USA. christosballas@yahoo.com

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary

Ziprasidone (Geodon) is an atypical antipsychotic for schizophrenia, reviewed for its unique pharmacology, clinical uses, and side effects. Future market changes are also considered.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation, Steady-State and Passivation Regimes for Ethene Hydrogenation over a Pd/Al <b><sub>2</sub></b> O <b><sub>3</sub></b> Catalyst: An <i>Operando</i> Neutron Imaging Study.

The journal of physical chemistry. C, Nanomaterials and interfaces·2026
Same author

A Case of Euglycemic Diabetic Ketoacidosis: SGLT2 Inhibitor Complication Triggering Acute Coronary Syndrome and Cardiac Arrest Post Coronary Artery Bypass Grafting (CABG).

Cureus·2025
Same author

A Review on the Etiologies of the Development of Atrial Fibrillation After Cardiac Surgery.

Biomolecules·2025
Same author

Pulmonary Embolism in the Elderly: From Symptoms to Speckle Tracking Echocardiography.

Journal of cardiovascular development and disease·2025
Same author

Effects of Concomitant Use of Various Psychotropic Medications on the Treatment Response to Transcranial Magnetic Stimulation for Depression: A Literature Review.

Cureus·2024
Same author

In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices.

Journal of cardiovascular development and disease·2024

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Therapeutics

Background:

  • Ziprasidone (Geodon) is an atypical antipsychotic.
  • It is approved for schizophrenia treatment.
  • Off-label uses are common.

Purpose of the Study:

  • To review ziprasidone's properties.
  • To examine pharmacodynamics, receptor binding, and clinical outcomes.
  • To assess side effects, drug interactions, and novel applications.

Main Methods:

  • Literature review of pharmacodynamic parameters.
  • Analysis of receptor-binding data.
  • Examination of clinical trial outcomes and market trends.

Main Results:

Related Experiment Videos

  • Ziprasidone has a unique pharmacological profile.
  • Established indications include schizophrenia.
  • Emerging therapeutic applications are under investigation.

    • Conclusions:

    • Ziprasidone is a versatile atypical antipsychotic.
    • Further research may expand its clinical utility.
    • Market evolution is anticipated in the next five years.